Factors associated with emotional distress in newly-diagnosed prostate cancer identified
the ONA take:
According to a new study published in the journal Psycho-Oncology, researchers from the University at Buffalo Department of Community Health and Health Behavior in Buffalo, New York, have identified certain factors associated with emotional distress in men with newly diagnosed prostate cancer.
For the study, researchers sought to identify factors associated with significant emotional distress in men with newly diagnosed prostate cancer so that may identify acceptable intervention strategies to manage that distress.
Researchers identified 1,425 men with newly diagnosed clinically localized prostate cancer who had not received treatment for their disease yet.
Participants used the Distress Thermometer to report how much distress they were experiencing and identify what problems they experienced in the past week. Results showed that low self-efficacy for decision-making, low confidence in cancer control, masculine identity threat, low optimism, and low resilience were associated with higher emotional distress.
The findings suggest that improving communication about prostate cancer prognosis, providing decision-making support, and referring to brief cognitive behavioral interventions may be useful approaches at mitigating significant emotional distress for those with newly diagnosed prostate cancer.
Researchers identified certain factors associated with emotional distress in men with newly diagnosed prostate cancer.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|